Work Here?
Work Here?
Work Here?
Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.
Company Stage
IPO
Employees
501-1,000
Industries
Biotechnology, Healthcare
Total Funding
$813.4M
Headquarters
N/A
Founded
1993
Find jobs on Simplify and start your career today